Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

This publication has 55 references indexed in Scilit:

• Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?: Lack of efficacy of promazine on SARS-CoV replication in a mouse model
  Antiviral Research, 2008
• Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
  Antiviral Research, 2005
• Emergence of methicillin-resistant Staphylococcus aureus with Panton?Valentine leukocidin genes in central Europe
  European Journal of Clinical Microbiology & Infectious Diseases, 2004
• Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
  Biochemical and Biophysical Research Communications, 2004
• Structure-Based Preliminary Analysis of Immunity and Virulence of SARS Coronavirus
  Viral Immunology, 2004
• Temporal Relationship of Viral Load, Ribavirin, Interleukin (IL)–6, IL‐8, and Clinical Progression in Patients with Severe Acute Respiratory Syndrome
  Clinical Infectious Diseases, 2004
• Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003
  Tropical Medicine & International Health, 2004
• Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells
  Life Sciences, 2004
• HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
  Biochemical and Biophysical Research Communications, 2004
• Recent progress in antiviral chemotherapy for respiratory syncytial virus infections
  Expert Opinion on Investigational Drugs, 2000